On Monday, U.S. stocks closed higher, with surging technology stocks pushing the Nasdaq 100 Index (+306 points or 2.88% to 10952) to another record close. The Dow Jones Industrial Average added 8 points to 26680, and the S&P 500 rose 27 points (+0.84%) to 3251.
Nasdaq 100 Index: Daily Chart
Source: GAIN Capital, TradingView
Market sentiment was boosted by positive trial results from several potential COVID-19 vaccines.
Retailing (+4.46%), Software & Services (+3.16%) and Semiconductors & Semiconductor Equipment (+2.25%) sectors perform the best. Amazon.com (AMZN +7.93%), Citrix Systems (CTXS +7.64%), Adobe Systems (ADBE +5.28%) and Microsoft (MSFT +4.30%) were among the top gainers.
Chevron (CVX -2.2%) said it has agreed to buy Noble Energy (NBL +5.44%) for $5 billion in an all-stock deal.
On the technical side, about 53.4% (52.2% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average, and 81.2% (80.4% in the prior session) were trading above their 20-day moving average.
European stocks were broadly higher. The Stoxx Europe 600 Index rose 0.75%. Germany's DAX 30 jumped 0.99%, France's CAC 40 climbed 0.47%, while the U.K.'s FTSE 100 eased 0.46%.
The benchmark U.S. 10-year Treasury yield drifted lower to 0.615%.
Spot gold price was up for a second session rising $7.00 (+0.4%) to $1,817 an ounce.
U.S. WTI crude oil futures (August) settled 0.5% higher at $40.81 a barrel, lifted by growing risk-on appetite.
On the forex front, the ICE U.S. Dollar Index slipped 0.1% on day to 95.82, the lowest level since March.
EUR/USD gained 0.2% to 1.1453. European Council President Charles Michel said he is confident that agreement on the bloc's stimulus package can be reached after putting forward a new proposal.
GBP/USD rose 0.7% to 1.2660.
USD/JPY climbed 0.2% to 107.25.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.
Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.